menu
    • menu

    Find Technivie manufacturers, exporters & distributors on PharmaCompass

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    0

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    3

    FDF Dossiers

    FDF Dossiers

    1

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    17

    US Patents

    0

    US Exclusivities

    5

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    7

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    48

    Finished Drug Prices

    Listed Dossiers

    3 RELATED EXCIPIENT COMPANIES

    7EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Ombitasvir & paritaprevir & ritonavir, Ombitasvir + paritaprevir + ritonavir, Ombitasvir / paritaprevir / ritonavir, Ombitasvir and paritaprevir and ritonavir, Ombitasvir mixture with paritaprevir and ritonavir, S900007110
    Molecular Formula
    C127H158N20O20S3
    Molecular Weight
    2380.9  g/mol
    InChI Key
    AKWYQCOPWKTDIP-SRFJDUAHSA-N
    Technivie
    1 2D Structure

    Technivie

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide;methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;1,3-thiazol-5-ylmethyl N-[(2S,5S)-3-hydroxy-5-[[3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
    2.1.2 InChI
    InChI=1S/C50H67N7O8.C40H43N7O7S.C37H48N6O5S2/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9;1-24-21-42-33(22-41-24)35(48)43-32-16-6-4-2-3-5-11-25-20-40(25,39(51)46-55(52,53)27-17-18-27)45-36(49)34-19-26(23-47(34)38(32)50)54-37-30-14-8-7-12-28(30)29-13-9-10-15-31(29)44-37;1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63);5,7-15,21-22,25-27,32,34H,2-4,6,16-20,23H2,1H3,(H,43,48)(H,45,49)(H,46,51);6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/b;11-5-;/t38-,39-,40-,41-,42-,43-;25-,26-,32+,34+,40-;28-,31-,32?,33?/m010/s1
    2.1.3 InChI Key
    AKWYQCOPWKTDIP-SRFJDUAHSA-N
    2.1.4 Canonical SMILES
    CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O.CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
    2.1.5 Isomeric SMILES
    CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)CC([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O.CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. Ombitasvir & Paritaprevir & Ritonavir

    2. Ombitasvir + Paritaprevir + Ritonavir

    3. Ombitasvir / Paritaprevir / Ritonavir

    4. Ombitasvir And Paritaprevir And Ritonavir

    5. Ombitasvir Mixture With Paritaprevir And Ritonavir

    6. S900007110

    2.3 Create Date
    2015-08-01
    3 Chemical and Physical Properties
    Molecular Weight 2380.9 g/mol
    Molecular Formula C127H158N20O20S3
    Hydrogen Bond Donor Count11
    Hydrogen Bond Acceptor Count28
    Rotatable Bond Count41
    Exact Mass2380.11569587 g/mol
    Monoisotopic Mass2379.11234103 g/mol
    Topological Polar Surface Area579 Ų
    Heavy Atom Count170
    Formal Charge0
    Complexity4190
    Isotope Atom Count0
    Defined Atom Stereocenter Count13
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Emulsifying Agents

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ombitasvir / paritaprevir / ritonavir Manufacturers

    A Ombitasvir / paritaprevir / ritonavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ombitasvir / paritaprevir / ritonavir, including repackagers and relabelers. The FDA regulates Ombitasvir / paritaprevir / ritonavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ombitasvir / paritaprevir / ritonavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    Ombitasvir / paritaprevir / ritonavir Suppliers

    A Ombitasvir / paritaprevir / ritonavir supplier is an individual or a company that provides Ombitasvir / paritaprevir / ritonavir active pharmaceutical ingredient (API) or Ombitasvir / paritaprevir / ritonavir finished formulations upon request. The Ombitasvir / paritaprevir / ritonavir suppliers may include Ombitasvir / paritaprevir / ritonavir API manufacturers, exporters, distributors and traders.

    Ombitasvir / paritaprevir / ritonavir GMP

    Ombitasvir / paritaprevir / ritonavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Ombitasvir / paritaprevir / ritonavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ombitasvir / paritaprevir / ritonavir GMP manufacturer or Ombitasvir / paritaprevir / ritonavir GMP API supplier for your needs.

    Ombitasvir / paritaprevir / ritonavir CoA

    A Ombitasvir / paritaprevir / ritonavir CoA (Certificate of Analysis) is a formal document that attests to Ombitasvir / paritaprevir / ritonavir's compliance with Ombitasvir / paritaprevir / ritonavir specifications and serves as a tool for batch-level quality control.

    Ombitasvir / paritaprevir / ritonavir CoA mostly includes findings from lab analyses of a specific batch. For each Ombitasvir / paritaprevir / ritonavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Ombitasvir / paritaprevir / ritonavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Ombitasvir / paritaprevir / ritonavir EP), Ombitasvir / paritaprevir / ritonavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ombitasvir / paritaprevir / ritonavir USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search